Author Question: Investigations of family intervention programs for the treatment of schizophrenia have found that ... (Read 45 times)

vHAUNG6011

  • Hero Member
  • *****
  • Posts: 514
Investigations of family intervention programs for the treatment of
   schizophrenia have found that they ______.
 
  a. reduce the risk of recurrent episodes of schizophrenia
  b. have no effect on the risk of recurrent episodes of schizophrenia
  c. increase the risk of recurrent episodes of schizophrenia
  d. increase the risk that other family members will develop schizophrenia

Question 2

In the 1979 case of Rogers v. Okin, the court ruled that ______ has a right to exercise bad
   judgment within certain broad limits.
 
  a. neither a patient with a mental illness nor one without a mental illness
  b. a patient with a mental illness, but not a patient without a mental illness
  c. a patient without a mental illness, but not a patient with a mental illness
  d. a patient with or without a mental illness



bfulkerson77

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

A

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library